Skip to main content
Premium Trial:

Request an Annual Quote

C2i Genomics, OncoDNA Enter Strategic Alliance for AI-Based Cancer Detection, Monitoring

NEW YORK – Cancer diagnostic company C2i Genomics said Monday that it has entered a strategic partnership with precision medicine company OncoDNA to pair C2i's artificial intelligence-based whole-genome sequencing and minimal residual disease cancer monitoring platform with OncoDNA's European network of cancer clinician-researchers.

The partnership, which expands C2i into Europe, will also support an interventional clinical trial led by Paris' Gustave Roussy Institute to test the clinical utility of escalating metastatic treatments in over 750 patients with high risk of cancer recurrence following standard of care. The study includes detection of circulating tumor DNA and seeks conclusive evidence of the benefits of C2i’s cancer detection technology across various solid cancers, including lung cancer, breast cancer, sarcoma, and gastrointestinal cancers. 

C2i and OncoDNA will provide cancer monitoring and analytic services for that trial.

C2i's partnership with OncoDNA follows other deals that have expanded C2i's market reach over the past year. These include alliances with NuProbe Global, Premier, and NovogeneAIT Genomics, taking the company into China, the US, and East Asia, respectively.

"C2i’s whole-genome technology provides ultra-high sensitivity with significantly reduced lab operation complexity, eliminating the need to develop a patient-specific assay, and allowing rapid and high-throughput solution for cancer patients across the EU," Jean-Pol Detiffe, founder of OncoDNA, said in a statement.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.